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Abstract
There is mounting evidence that the aerosol transmission route plays a significant role in the spread of influenza in
temperate regions and that the efficiency of this route depends on humidity. Nevertheless, the precise mechanisms by
which humidity might influence transmissibility via the aerosol route have not been elucidated. We hypothesize that
airborne concentrations of infectious influenza A viruses (IAVs) vary with humidity through its influence on virus inactivation
rate and respiratory droplet size. To gain insight into the mechanisms by which humidity might influence aerosol
transmission, we modeled the size distribution and dynamics of IAVs emitted from a cough in typical residential and public
settings over a relative humidity (RH) range of 10–90%. The model incorporates the size transformation of virus-containing
droplets due to evaporation and then removal by gravitational settling, ventilation, and virus inactivation. The predicted
concentration of infectious IAVs in air is 2.4 times higher at 10% RH than at 90% RH after 10 min in a residential setting, and
this ratio grows over time. Settling is important for removal of large droplets containing large amounts of IAVs, while
ventilation and inactivation are relatively more important for removal of IAVs associated with droplets ,5 mm. The
inactivation rate increases linearly with RH; at the highest RH, inactivation can remove up to 28% of IAVs in 10 min.
Humidity is an important variable in aerosol transmission of IAVs because it both induces droplet size transformation and
affects IAV inactivation rates. Our model advances a mechanistic understanding of the aerosol transmission route, and
results complement recent studies on the relationship between humidity and influenza’s seasonality. Maintaining a high
indoor RH and ventilation rate may help reduce chances of IAV infection.
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Introduction
Influenza A has a clear seasonal pattern in temperate regions,
yet the underlying cause for it remains controversial despite nearly
a century of investigation. The literature identifies numerous
factors that may influence influenza’s seasonality: environmental
conditions such as temperature, humidity, and ultraviolet
radiation; immune function; school schedules; and human
mobility patterns and contact rates [1]. Among these, the leading
contenders are humidity and temperature [2,3,4], and in indoor
environments, where people spend ,90% of their time, humidity
is the more variable factor. Particularly in the developed world
where heating, ventilation, and air conditioning systems (HVAC)
are the norm, indoor temperature tends to fall in a narrower
range, and thus its influence is limited. Recent studies using a
guinea pig experimental model [3,4] indicate that low relative
humidity (RH) favors aerosol transmission of influenza A viruses
(IAVs), in which they are transmitted by small respiratory droplets
expelled from infected hosts. Nevertheless, the precise mechanisms
by which humidity might influence influenza viability and
transmissibility via the aerosol route have not been elucidated.
Humidity may affect airborne IAV transmission via two
important variables. The first is droplet size. When released from
the respiratory tract (assumed to have 100% RH), droplets
experience rapid evaporation and shrinkage upon encountering
the unsaturated ambient atmosphere. The ultimate size of a
droplet depends on ambient humidity, and size determines
aerodynamic behavior and whether the droplet will settle to the
ground quickly or remain suspended in the air long enough to
possibly cause a secondary infection. Previous studies on
evaporation of respiratory droplets usually used water or simple
saline solutions (e.g., NaCl) to simulate respiratory fluid [5,6].
However, respiratory fluid is a complicated combination of water,
salts, and various organic compounds [7,8] that affect the
thermodynamics of evaporation, compared to pure water or
saline solutions. The equilibrium droplet size is affected by surface
curvature and solute effects, the combination of which is described
by Ko¨hler theory [9]. While the vapor pressure is enhanced over
curved versus flat surfaces, it is reduced by the presence of solutes.
These competing effects are magnified at smaller droplet
diameters and determine the equilibrium size at a particular RH.
The second variable that is sensitive to humidity is IAV viability
[2,10,11,12,13]. Hemmes et al. [2] linked influenza’s seasonality to
the seasonal oscillation of RH indoors, based on their experiment on
death-rate variation versus RH. Shaman and Kohn [14], on the
other hand, concluded that absolute humidity (AH) rather than RH
modulates influenza seasonality through constraint on viability, but
whether AH or RH is controlling is under debate. For our purposes,
differentiating between the two is not possible because this work
focuses on a narrow range of typical indoor temperatures. Finally, it
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21481
is possible that the two variables—final droplet size and viability—
are linked, if evaporation and subsequent concentration of solutes in
respiratory droplets affects IAV viability in aerosols.
Elucidating the causes of influenza’s seasonality will require
improved comprehension of transmission mechanisms, especially
the aerosol route. To advance a mechanistic understanding of the
role of humidity in aerosol transmission, we model the change in
size of respiratory droplets and IAV inactivation at RHs ranging
from 10% to 90%. Based on these results, we further model the
dynamics of droplets emitted from a cough in an indoor
environment and illustrate the evolution of infectious IAV
concentrations and size distributions, considering removal by
gravitational settling, ventilation, and viral inactivation. We are
thus able to determine the magnitude by which humidity affects
airborne concentrations of infectious IAVs.
Results
Initial size distribution of droplets expelled from a cough
We located seven papers that reported the size distribution of
droplets expelled while coughing, sneezing, and speaking
[6,15,16,17,18,19,20]. The droplet diameter geometric mean
(GM), size range, and droplet number varied greatly among the
different studies, as summarized in Table 1. Because ,80% of
patients with influenza manifest symptoms of coughing [21], we
focus on droplets emitted from coughing to demonstrate the
dynamics of airborne IAVs. Droplet diameters as small as 0.3 mm
and as large as 2000 mm have been observed from coughing, and
the GMs in the studies ranged from 0.25 mm to 96.6 mm,
depending on the experimental methods used (Table 1). Four of
the studies reported GMs in a much narrower range of 8.4 mm to
16.0 mm. We adopted Duguid’s [20] results on the basis of
reliability of the methods and care and thoroughness of the
experimental design and analysis. Though the study dates to 1946,
its results were similar to those of more contemporary work that
use modern aerosol characterization equipment [6,17]. Similar to
Nicas et al. [22], we found that droplets between 1–100 mm from
coughing follow a log-normal size distribution. Eq. 1 describes the
relationship:
z~1:216 lnDi{3:113 r
2~0:997
  ð1Þ
where Di is the initial droplet diameter in mm, and z is the
corresponding quantile of a normal distribution with the same
cumulative probability. According to this relationship, the size
distribution of droplets emitted from coughing has a GM of
12.9 mm and a geometric standard deviation (GSD) of 2.3
(Figure 1).
Respiratory droplet size transformation
Equilibrium droplet size is attained nearly instantaneously upon
release. A 20-mm droplet shrinks to one-half of its original
Table 1. Prior studies of respiratory droplet size distributions.
Activity Droplet size (mm)
Droplet
number
Experimental
conditions Measurement methods
Adjustment for
evaporationb Reference
GM (GSD)a Range
Cough 12.1 (2.6)c 1–2000 5000 NA Microscope Factor of 4 [20]
16.0 (5.8)d 1R1471 466 NA Bone paper and 0.45-mm filter As measured [15]
0.5 (1.7)e ,0.6–2.5 420 24uC, 45%RH;
35uC, 23%RH
Optical particle counter
(OPC), electron microscope
As measured [16], [22]
8.4 (2.2) NA NA 95% RH Aerodynamic particle
sizer (APS), scanning
mobility particle sizer, OPC
As measured, assumed
to be the original size
[17]
13.5f 2–1000 NA 24.9uC, 73.9% RH Interferometric Mie
imaging (.2 mm),
particle image velocimetry
As measured [6]
1.8g 0.3–20 NA 27uC, 59.4% RH Expiratory droplet
investigation system, APS
As measured [18]
96.6 (2.4)h 0–1500 42 28uC, 70% RH Microscope, aerosol
spectrometer
Factor of 3 [19]
Sneeze 8.2 (2.3)c 1–2000 16106 NA Microscope Factor of 4 [20]
Speaki 11.9 (2.8)c 1–1000 252 NA Microscope Factor of 4 [20]
16f 2–1000 NA 24.9uC, 73.9% RH Interferometric Mie
imaging (.2 mm),
particle image velocimetry
As measured [6]
62.1 (1.8)h 0–1000 253 28uC, 70% RH Microscope, aerosol
spectrometer
Factor of 3 [19]
aGeometric mean (GM) and geometric standard deviation (GSD) calculated by methods presented in [51] or cited as reported in the original papers.
bWhether droplet sizes were adjusted upward to account for evaporation or were reported as measured.
cCalculated from data in Table 3 in [20].
dCalculated from data in Table 1 in [15]; droplet diameter upper end assumed to be 2000 mm.
eCalculated from data in Table IV in [22].
fNo data on GSD reported.
gReported modal diameter.
hCalculated from data in Table 2 in [19], only results from experiments without food dye were used.
iCounting aloud from 1 to 100.
doi:10.1371/journal.pone.0021481.t001
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diameter in less than half a second at 20uC [22]. Table 2 shows the
equilibrium, or final, diameters (Deq) of droplets with Di of 0.1, 1,
and 10 mm at 10–90% RH. These were calculated based on a
model of droplet transformation that assumes separate solutes and
volume additivity (SS-VA) [23]. Due to the Kelvin effect,
evaporation of smaller droplets is enhanced, and the equilibrium
diameters are smaller. The ratio Deq/Di is 0.490 at 90% RH for a
respiratory droplet with Di=0.1 mm, versus 0.516 under the same
conditions for a larger one with Di=10 mm. However, the Kelvin
effect is negligible for droplets with Di.0.1 mm, and Deq/Di is
independent of RH for droplets larger than 1 mm.
Efflorescence or crystallization of NaCl, a major component of
respiratory droplets, due to loss of water is expected to occur
between 40–50% RH [24]. According to our results, between 10–
40% RH, Deq/Di varies by only 3.7% (0.402–0.417); in
comparison, between 50–90% RH, the ratio varies by 21.7%
(0.424–0.516). Respiratory droplets lose almost all their water at
low RHs. For comparison, we also calculated the Deq/Di ratios
based on volume additivity using experimental data on dehydra-
tion of droplets containing NaCl [25] and on hydration of those
containing a glycoprotein [26]. Differences between modeled and
experimental results are less than 4% (Table 2).
Inactivation of airborne IAVs
The viability of IAVs decreases over time and is affected by
environmental variables such as temperature, humidity, and UV
radiation [12,27]. The inactivation rate (k), derived from
experimental data on airborne IAVs [12], is linearly correlated
with RH (Figure 2), following the relationship
k~0:0438RH{0:00629 ð2Þ
with an r2 of 0.977 and p-values for the model, intercept, and slope
of 0.0015, 0.059, and 0.0015, respectively.
Evolution of infectious IAV distribution after a cough
The well-mixed indoor air model we developed for infectious
IAVs accounts for removal by gravitational settling, ventilation,
and viral inactivation. The concentration of infectious IAVs
associated with droplets of a specific diameter Deq in a room at
time t is
C~C0 exp½{( v
H
zlzk)t ð3Þ
where C0 is the initial concentration of infectious IAVs associated
with droplets of size Deq in the room, v is the settling velocity, H is
the height of the room, l is the air exchange rate (AER) and
assumes no recirculation, and k is the inactivation rate. The
inactivation rate k depends on RH, according to Eq. 2, and the
settling velocity v depends on Deq, which also depends on RH. Eq.
3 can be integrated over all droplet sizes to obtain the total
concentration of infectious IAVs in a room. We calculate results
for AERs of 1 air change per hour (ACH) and 10 ACH, typical of
residential and public settings, respectively [28,29]. For simplicity,
we assumed that room heights are the same in residences and
public settings such as offices, classrooms, and hospitals, where
people aggregate and thus have a higher risk of infection. The
equation is applicable for a single rectangular room, does not
depend on the volume of the room, and does not account for air
exchange between multiple rooms.
Table 2. Respiratory droplet size transformation.
RH Model-based Deq/Di ratios
a
Experimentally derived Deq/Di ratios
b Diff.c
Di=0.1 mm Di=1 mm Di=10 mm
10% 0.401 0.402 0.402 0.391 2.61%
20% 0.407 0.407 0.407 0.395 3.06%
30% 0.412 0.412 0.412 0.398 3.42%
40% 0.416 0.417 0.417 0.401 3.98%
50% 0.422 0.423 0.424 0.427 20.90%
60% 0.429 0.431 0.432 0.437 21.19%
70% 0.439 0.443 0.444 0.449 21.20%
80% 0.456 0.464 0.465 0.464 0.02%
90% 0.490 0.513 0.516 0.502 2.63%
aCalculated according to the SS-VA model of Mikhailov et al. [23].
bCalculated based on volume additivity using experimental data from Tang et al. [25] and Bagger et al. [26].
cDifference between modeled and experimental Deq/Di ratios for Di= 10 mm.
doi:10.1371/journal.pone.0021481.t002
Figure 1. Log-probability plot of droplet size distribution from
a cough, adapted from Duguid [20]. Di is the initial droplet size in
mm, and z is the corresponding quantile of a normal distribution with
the same cumulative probability.
doi:10.1371/journal.pone.0021481.g001
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Figure 3 shows the evolution of IAV concentrations in time in
terms of both the total number of infectious viruses (Figure 3A and
3B) and size distribution (Figure 3C and 3D). Only emitted
droplets with Di#100 mm are considered, as larger ones will be
removed by gravitational settling within seconds. Following a
single cough in a well-mixed room, the concentration of infectious
IAVs is initially 1.86103 # m23 under the assumptions of this
study. Figures 3A and 3B show that the total number of infectious
IAVs falls rapidly with time and that the loss is greater at higher
RH and in public versus residential settings. If one infected person
is continuously shedding viruses by coughing 15 times per hour
[30], then the concentration of IAVs will be ,26103 # m23 in a
public setting. This concentration is similar in magnitude to those
measured in hospitals, medical clinics, day care facilities, and
airplanes [31,32,33]. Under conditions of higher RH, removal by
settling is more effective because droplets shrink less, and
inactivation is more rapid. Removal of 99.9% of the IAVs emitted
requires much greater time in a residential versus public setting,
indicating that ventilation is an important removal mechanism and
that airborne IAVs can persist for longer times in settings with
lower AERs.
Figure 3C and 3D show that, at 50% RH, emitted droplets
shrink to about half of their original diameters due to evaporation.
Evaporation happens almost instantaneously [22], so while the
initial size distribution at 0 min extends out to 100 mm, all
subsequent ones end at 42 mm (Deq/Di=0.42). This process greatly
increases the fraction of IAVs that are associated with smaller
droplets, since the virus concentration within a droplet increases
by a factor of 8 (23) as its diameter shrinks by half. For instance,
compared to the initial droplets emitted at 0 min, which quickly
reach their equilibrium diameters, the number of IAVs associated
with equilibrium droplet sizes smaller than 25 mm increases by a
factor of 5.2 at 50% RH. Due to more rapid settling, IAVs
associated with larger droplets are lost faster than are those
associated with smaller ones. Consequently, IAVs associated with
smaller droplets become more dominant over time, as indicated by
the shifting of the peak of DC/DDeq to the left in Figure 3C and
3D. The diameter of droplets containing the most IAVs (i.e., the
mode of the distribution) shifts from ,50 mm upon release to
,16 mm at 1 min, ,10 mm at 10 min, and ,5 mm at 60 min in
residential settings; a similar trend is shown in Figure 3D for public
settings.
Humidity dependency and removal mechanisms
Figure 4 shows the effect of RH on size distributions of
infectious IAVs, 10 min after a cough in residential and public
settings. For both cases, IAV concentrations decrease with
increasing RH across all sizes, but the modes of the distributions
remain around 9–10 mm. The total IAV concentration (i.e., the
area under each curve) decreases with increased RH. As a result, it
takes twice as long to remove 99.9% of IAVs emitted at 10% RH
than that at 90% RH in residential settings (.100 min at 10% RH
versus ,50 min at 90% RH, as shown in Figure 3A).
Humidity affects both settling, because of its dependence on size
transformation, and inactivation of IAVs. The relative importance
of these two effects can be illustrated by comparing the ratios of
virus concentrations at 10% RH versus those at 90% RH at
varying times. The ratios increase approximately exponentially
with time: 2.4 at 10 min, 5.4 at 30 min, and 16.1 at 60 min. If
only inactivation were considered, these factors would instead be
1.4, 2.7, and 7.3, respectively; and if only settling were considered,
the corresponding factors would be 1.7, 2.0, and 2.2, respectively.
These ratios are independent of the ventilation rate. The much
narrower range of factors for settling than for inactivation (i.e.,
1.7–2.2 versus 1.4–7.3) indicates that RH has a greater impact on
inactivation, especially over long periods (.30 min).
Figure 5 shows the effectiveness of each removal mechanism—
settling, ventilation, and inactivation—independently as a function
of RH (Figure 5A and 5B) and droplet size (Figure 5C and 5D),
10 min following a cough. Figure 5A shows that gravitational
settling is the dominant removal mechanism in residential settings.
Settling alone removes over 80% of airborne IAVs within 10 min,
and its removal efficiency increases slightly with RH, from 87% to
92% across the range of RHs. In contrast, ventilation only
removes 15% of total IAVs, regardless of RH. Removal efficiency
by inactivation increases with RH, accounting for up to 28% at the
highest RH. Figure 5B shows that ventilation and gravitational
settling are both important in removing airborne IAVs from public
settings with higher AERs. At an AER of 10 ACH with no
recirculation, ventilation removes 81% of airborne IAVs. Settling
and inactivation are independent of ventilation rate and remove
the same amounts of IAVs as in residential settings.
Removal efficiencies for IAVs vary as a function of droplet size
for settling but not ventilation or inactivation. Figure 5C and 5D
show removal efficiency versus equilibrium droplet diameter at
50% RH, 10 min following a cough, for each mechanism
individually and all three together. Because settling velocity scales
with diameter squared, removal efficiencies due to gravitational
settling range from only 0.7% for droplets with Deq=1 mm to
51.2% for those with Deq=10 mm to .98.8% for those with
Deq.25 mm. Ventilation is equally effective for all sizes, with
removal efficiencies of 15% in residential settings (Figure 5C) and
81% in public settings (Figure 5D), depending on the AER.
Overall, gravitational settling is the main removal mechanism in
both residential and public settings (Figure 5A and 5B). It removes
a disproportionately large fraction of IAVs because it favors larger
droplets, which contain far more IAVs, as their numbers are
proportional to the initial droplet volume, or Di
3. However,
settling is ineffective at removing droplets ,5 mm, as shown in
Figure 5C and 5D. Ventilation is important in public settings and
particularly so for removal of smaller droplets (,5 mm) for which
settling is inefficient. It accounts for ,50% of total removal of
IAVs associated with droplets ,5 mm in residential settings
(Figure 5C) and ,80% in public settings (Figure 5D). Inactivation
increases with RH and is maximal at 28% at 90% RH, 10 min
following a cough (Figure 5A and 5B). Although the removal
efficiency by inactivation is relatively low, it is important when
Figure 2. IAV inactivation rate versus RH. IAV inactivation rates (k)
for each RH over 1 h were calculated based on experimental data
adapted from Harper [12].
doi:10.1371/journal.pone.0021481.g002
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removal by ventilation and settling are both minor. For instance,
in residential settings (Figure 5C), inactivation accounts for ,50%
of total removal of IAVs associated with droplets ,5 mm.
Discussion
Removal of infectious IAVs
Higher RH favors removal of infectious IAVs. Since larger
droplets have greater settling velocities, higher RHs, at which
Deq/Di is larger, thereby will accelerate the removal rate.
Additionally, the inactivation rate of IAVs increases with
increasing RH (Eq. 2). According to our model, the concentration
of airborne IAVs resulting from a cough would be reduced by
10% if the RH increases from 35%, the mean indoor RH in
heating season [30], to 50%, 10 min following the cough, and by
40% after 1 h in residential settings. These estimates agree in
magnitude with those reported by Myatt et al. [30], whose model
suggests that influenza virus survival decreases by 17.5–31.6%
when indoor RH increases by 11–19% over 15 h. Hence,
maintaining a reasonably high indoor RH (e.g., 50%) may
Figure 3. Evolution of infectious airborne IAV concentrations and size distributions. Time series of airborne, infectious IAV concentrations
following a cough into residential (A) and public (B) settings at 10–90% RH. The horizontal dashed line indicates 99.9% removal. Evolution over time
of airborne, infectious IAV size distribution following a cough into residential (C) and public (D) settings at 50% RH.
doi:10.1371/journal.pone.0021481.g003
Figure 4. IAV size distributions. Infectious IAV size distributions at various RHs in residential (A) and public (B) settings with a volume of 50 m3
and a height of 2.5 m, 10 min after a cough.
doi:10.1371/journal.pone.0021481.g004
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accelerate the removal of infectious IAVs and help prevent or
reduce influenza infection.
The relative importance of the two mechanisms—droplet size
transformation and inactivation—as a function of humidity is of
interest. Shaman and Kohn [14] concluded that AH modulates
influenza transmission by influencing the virus’ survival rate, rather than
by enhancing production of airborne droplet nuclei in low humidity
conditions.We found that respiratory droplets would shrink to one-half
of their original diameters at 90%RH, and to around two-fifths at 10%
RH. It thus appears that changes in droplet size are dramatic at
unsaturated RHs and that variations due to differences in RH are
relatively trivial. Our analysis shows that removal by inactivation is
more variable with RH than is removal by settling. This may explain
why Shaman and Kohn [14] could find a statistically significant
relationship between AH and influenza survival but not transmission.
However, this does not suggest that droplet shrinkage in response to
unsaturatedRHs is not important for influenza transmission, only that it
is not as obvious as the induced change in viability.
We have demonstrated the relative importance of the three removal
mechanisms. Settling can remove over 80% of droplets emitted from a
cough within 10 min; however, it is effective only for larger droplets
and allows the smaller ones (,5 mm) to remain suspended. In contrast,
ventilation is able to remove all droplets regardless of size simply by air
exchange. Therefore, higher AERs will facilitate the elimination of
virus-containing droplets from indoor environments, especially to
compensate for the inefficacy of settling in removing the small ones.
This observation also justifies the requirement tomaintain a high AER
in public places (e.g., 12 ACH in hospital waiting areas [34]). Removal
efficiencies due to virus inactivation are relatively small (i.e., 0–28% in
10 min, if only inactivation were considered). However these estimates
are based on experimental data reported by Harper [12], which
indicated lower inactivation rates of 0.0031–0.028 min21 at 20–81%
RH, compared to 0.007360.0031 min21 at 15–40% RH and
0.09160.024 min21 at 50–90% RH, as reported by Hemmes [2].
If estimated Hemmes’ data [2], the corresponding removal efficiencies
would be larger: 7.0% at 15–40% RH and 59.8% at 50–90% RH.
Virus inactivation may thereby play a more significant role depending
on the actual inactivation rate.
IAV viability, seasonality, and humidity dependency
Experimental and/or theoretical models have been constructed to
predict the viability of airborne IAVs as a function of humidity
[14,35], but a widely accepted mechanistic explanation for the
relationship is still lacking. Studies on the effect of humidity agree that
IAVs survive better at lower RHs. However, Hemmes [2,11] and
Harper [12] found higher inactivation rates at both medium and high
RHs, in contrast to Shechmeister [10] and Schaffer et al. [13], who
found higher inactivation rates at medium but not high RHs. This
disparity may stem from the different compositions of media used in
each experiment. All media contained salts (approximately 0.5–3%);
however, those used in the former two experiments contained far
more proteins than did those in the latter two. High concentrations of
salts are found to be detrimental to avian IAVs [36]. As water in the
droplets evaporates, solute concentrations increase and may
Figure 5. IAV removal mechanisms. Infectious IAV removal efficiencies due to settling, ventilation, and inactivation in residential (A) and public
(B) settings at different RHs. Removal efficiency of settling, ventilation, and inactivation as a function of droplet size in residential (C) and public (D)
settings at 50% RH. Removal efficiencies are shown for each mechanism independently and do not sum to 100% because in actuality, more than one
mechanism may act on the same virus/droplet.
doi:10.1371/journal.pone.0021481.g005
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consequently accelerate IAV inactivation. However, an NaCl droplet
can suddenly lose all of its water and crystallize at the point of
efflorescence (45–48% RH) [25], thus eliminating the negative effect
of dissolved salts at low RHs. This effect is perceivable in Table 2,
which shows that Deq/Di varies little when RH#40%. The
combination of increasing salt concentrations followed by efflores-
cence as RH decreases may explain the trend observed by
Shechmeister [10] and Schaffer et al. [13].
Additionally, a study on aerosol transmission between guinea
pigs [3] indicated that transmission was inversely related to RH at
5uC, although experiments at 20uC showed a lower transmission
rate at 50% RH than at 65% RH. As 0% transmission was
observed at 80% RH, the inconsistent result at 50% or 65% RH
may be due to the stochastic nature of infection. If higher
transmission rates are due to higher viabilities, at least in part,
these results appear to agree with the trend reported by Hemmes
[2,11] and Harper [12]. Given the similar constitution of droplets
emitted from infected human and guinea pigs (i.e., salts plus
proteins), it seems reasonable to believe that IAVs associated with
droplets expelled from humans will be subject to higher
inactivation at higher RHs.
The relationship between IAV viability and RH may be due to
interactions among components of respiratory droplets (i.e.,
glycoproteins, salts, and water) and the virus that are sensitive to
concentration, which depends on the extent of evaporation, which
depends in turn on ambient humidity. Proteins may complicate
the effect of salt ions on IAVs by interacting with the salt ions and
counteracting their adverse effects. Studies have shown that IAVs
remain infectious much longer in the presence of respiratory
mucus [37,38]. Investigation into such interactions and the
possible complexes formed in respiratory droplets in response to
humidity variation at a molecular level is needed.
We speculate that the seasonality of influenza with its wintertime
peak in temperate regions is stimulated by more vigorous
evaporation of droplets at low RHs leading to higher suspended
concentrations of IAVs, combined with the sensitivity of aerosolized
IAVs’ viability to RH. When RH is ,90%, droplets shrink
approximately in half, leaving associated IAVs that can remain
suspended long enough to cause secondary infections. Our recent
measurements of size-resolved airborne IAV concentrations support
this assertion: 64% of the IAV genomes detected in a daycare center,
a health center, and airplanes were associated with fine particles
,2.5 mm (15% in the 0.25–0.5 mm fraction, 10% in the 0.5–1.0 mm
fraction, and 28% in the 1.0–2.5 mm fraction) [33]. These particles
can remain suspended for hours to days. Because of the many factors
involved in infection, it is still not clear which size of droplets is most
likely to transmit influenza, nor is it clear which region in human
airways is most susceptible to influenza infection. However, if we
simply consider deposition efficiency in human airways, the droplet
size with the highest deposition efficiency (,95%) in all regions of the
airways combined is,5 mm. For such droplets, deposition efficiency
is,10% in the tracheobrochial and alveolar regions; the majority of
the droplets deposit in the nasopharyngeal region. The droplet size
with the highest deposition efficiency (,17%) in the tracheobron-
chial and alveolar regions is ,2.5 mm [39]. Thus these smaller
droplets have greater potential both to remain suspended and to
deposit deeper into human airways.
At extremely high RHs, for example, close to 100% in tropical
regions during the rainy season, the droplets do not shrink as much
(Deq/Di=0.927 at 99% RH, and 0.755 at 98% RH, according to
our calculations). Droplets thus settle more quickly, rendering the
aerosol route relatively less important. However, due to less
evaporation, salts and glycoproteins remain at concentrations
closer to those found in the respiratory tract, and these
concentrations are not detrimental to the virus. As suggested by
Lowen et al. [40,41], other transmission routes (e.g., contact) may
dominate in the tropics. They also proposed that the airborne
route’s sensitivity to RH and temperature contributes to
seasonality in temperate regions while the contact route’s
insensitivity to the two variables contributes to year-round
influenza in tropical regions. Our analysis supports this hypothesis.
Model limitations
There are several limitations of our model. First, although the
model used to predict equilibrium droplet sizes has been
confirmed with experiments using NaCl-bovine serum albumin
(BSA) particles [23], further verification with actual respiratory
fluid is needed due to its complex composition. Furthermore, the
composition of respiratory fluid depends on the emission site (nose
or mouth) and source (upper or lower respiratory tract), as well as
the stage of infection. Inflamed airways secrete larger amounts of
mucus which consequently increase the dry mass of respiratory
fluid [42]. Therefore, the equilibrium size of emitted droplets may
be larger than presented here based on composition under healthy
conditions. On the other hand, saliva has much lower concentra-
tions of salts and glycoproteins [43,44], due to dilution by which
droplets emitted from coughing may have lower dry mass.
Second, the model is based on limited data obtained from
laboratory experiments. Not only are Harper [12] and other
studies of IAV viability in aerosolized droplets [10,11,13] decades
old, but none investigated inactivation rates as a function of
droplet size. More accurate measurements concerning the
influence of respiratory droplet size on IAV viability are needed
to better predict the fate of airborne IAVs.
Third, we calculated the IAV concentration based on a well-
mixed room model with no recirculation. This model assumes that
droplets are instantaneously, continuously, and evenly distributed
throughout the room. However, according to Lai and Cheng [45], it
takes at least 270 s for 10-mm droplets to mix thoroughly at 5 ACH.
It may take even longer for the system to become well-mixed at
lower AERs.More accurate calculations may be achieved by the use
of computational fluid dynamics. Additionally, if recirculation
accounts for a large fraction of the AER and if viruses are not
removed in the HVAC system, then ventilation will play a relatively
smaller role in virus removal compared to settling and inactivation.
Finally, this research demonstrates the evolution of IAV
concentrations induced by a cough but not other activities, such
as normal respiration, talking, and sneezing. Fabian et al. [46]
determined that IAV RNA (i.e., potentially infectious IAVs) was
emitted in exhaled breath from infected patients at a rate of ,3.2
to 20 RNA particles min21. These droplets were smaller than
those associated with a cough; over 87% of them were ,1 mm in
diameter. Therefore, for IAVs exhaled during normal breathing,
because of the smaller droplet size, airborne IAV concentrations
would be lower and removal would rely more on ventilation and
inactivation than gravitational settling. IAVs may also be expelled
during talking, although to our knowledge, no detailed experi-
mental data on this phenomenon are currently available in the
literature. The droplet size distribution for talking is similar to that
for coughing (Table 1). Therefore, model results are expected to be
similar for IAVs generated by talking in terms of removal
efficiencies by different mechanisms. Sneezing is a less common
clinical manifestation of influenza than is coughing, which is
manifested in ,80% of patients [21,46,47,48]. The main
difference between sneezing and coughing is that the former
generates far more droplets, especially smaller ones. Thus, IAV
concentrations would be higher initially, and ventilation would
play a larger role in removal.
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Methods
Equations for generating the initial respiratory droplet
size distributions
From data on the size distribution of droplets expelled in a
cough [20], we considered counts of droplets with Di#100 mm.
The standard normal distribution z-value with the same
cumulative probability as that for droplets with a diameter Di
was computed by the NORMSINV function in Excel 2007. The
equation of the least-squares linear regression between z and lnDi
is shown in Eq. 1 and Figure 1.
The initial size distribution of droplets (#100 mm) from
coughing was then generated by the NORMSDIST function in
Excel 2007:
ni~N|(NORMSDIST(zi,upper){NORMSDIST(zi,lower)) ð4Þ
where ni is the droplet count in the ith size bin (5-mm step in this
study), N is the total number of droplets #100 mm (i.e., 4775
according to Duguid [20]), and zi, upper and zi, lower are the upper
and lower z values of the ith size bin.
Model for calculating equilibrium respiratory droplet size
The equilibrium droplet sizes resulting from evaporation were
estimated based on Ko¨hler theory taking into account the two major
constituents of respiratory fluid: inorganic salts and glycoproteins.
Effros et al. [7] determined concentrations (mean6 standard error)
of the major electrolytes to be, respectively, 9168 (Na), 60611 (K),
and 102617 (Cl) mM, of glycoproteins to be 76.3618.2 g L21, and
of lactate to be 44617 mM. We thereby assume respiratory fluid
contains 150 mM (8.8 g L21) NaCl to represent the inorganic
components and 76 g L21 of total proteins (TP) to approximate the
organic components, as done by Nicas et al. [22].
The SS-VA model derived by Mikhailov et al. [23] is based on
the physiochemical properties (practical osmotic coefficients,
molecular weights, and densities of the component solutes, etc.)
of the droplet and the Kelvin effect. Their modeling results for
particles with 90% BSA (dry mass fraction) fitted well with
experimental data for dehydration of mixed NaCl-BSA particles.
Given the similar composition of respiratory fluid (89.6% TP in
dry mass) to their NaCl-BSA particles, we applied their SS-VA
model to compute the equilibrium size for respiratory droplets.
The SS-VA model predicts the equilibrium RH with a specific
droplet diameter (Deq) to be:
RH~ exp (
4sMw
rRTDeq
{
Mw
rw((Deq{Dm,s)
3{1)
X
y
vyWyryxs,y
My
) ð5Þ
where, s is the surface tension (approximated by that of water as
done in Mikhailov et al. [23], i.e., 0.072 N m21); M is the molar
mass, the subscripts w and y refer to water and component y (either
NaCl or TP), respectively, and Mw=18 g mol
21, MNaCl = 58.4 g
mol21, MTP<MBSA=66.56103 g mol21; r, rw, ry are the
densities of the entire droplet, water, and component y
(rNaCl=2165 kg m
23, rTP<rBSA=1362 kg m23), respectively; R
is the ideal gas constant; T is the absolute temperature (298 K in
this study); Deq is the equilibrium diameter of a droplet residue at a
given RH; Dm,s is the mass equivalent diameter of a particle
consisting of the dry solutes; uy is the stoichiometric dissociation
number of component y, uNaCl = 2, and uTP= uBSA=1; Wy is the
molal or practical osmotic coefficient of component y describing
the non-ideality of the solution; and xs,y is the mass fraction of
component y (xNaCl=0.104 and xTP=0.896 in this study). Given
Di, the mass equivalent diameter, Dm,s, can be calculated and used
as an input to further calculate Deq with its equilibrium RH.
Virus inactivation rate
Harper [12] performed a detailed study on the viability of
airborne IAVs over a wide range of both RH and temperature. In
the experiment, droplets containing IAVs were generated with an
atomizer and stored in a drum turning at 3 rpm, and results were
corrected for physical loss by settling and other deposition
mechanisms. We used his viability data at 20–24.5uC, typical
indoor temperatures, at RHs ranging from 20% to 81% to
calculate inactivation rates as a function of RH (Table 3). Because
the residence time of air indoors is typically 1–2 h at most, we
considered viability data from the first 1 h of the experiment only.
We quantified viability by assuming that airborne IAVs undergo
first-order inactivation upon emission, such that,
dN
dt
~{kN ð6Þ
where N is the number of IAVs emitted, t is time, and the
inactivation rate (k) is
k~{
ln (
Nt
N0
)
t
~{
lnSt
t
ð7Þ
where N0 and Nt are the numbers of IAVs at t=0 and time t, and St is
the survival rate, or viability (%) at time t. Accordingly, we computed
k for each RH from the St data reported by Harper [12] using the
SLOPE function in Excel 2007 (Table 3). The equation of the least-
squares linear regression between k and RH is shown in Eq. 2.
Concentration of infectious IAVs indoors
The model for estimating the concentration of infectious IAVs
assumes that they are emitted from a cough and instantaneously
well-mixed within the whole indoor space such that IAV
concentrations in the room and outlet air are the same. The
IAVs are subjected to removal by ventilation, inactivation, and
gravitational settling. Droplet size transformation is assumed
complete at time zero, and Deq was used for the calculation.
Assuming the inlet air contains no IAVs, the change of IAV
concentration with time is modeled as:
dC
dt
~{(
v
H
zlzk)C ð8Þ
where C is the infectious IAV concentration in the room and
outflow (# m23); v is the gravitational settling velocity calculated
by Stokes law based on Deq; H is assumed to be 2.5 m in this study;
l is the air exchange rate assuming no recirculation; and k is the
inactivation rate given by Eq. 2.
At time zero, IAVs are released from a cough, and the initial
concentration of IAVs associated with droplets in the ith size bin,
Ci,0 (# m
23) is
Ci,0~0:778|6:3|10
{3|(
p
24
|
D4i,upper{D
4
i,lower
Di,upper{Di,lower
)(
ni
V
) ð9Þ
where 0.778 is the initial survival rate (i.e., the average survival
rate at 1 s according to the results of Harper [12]); 6.361023 is the
IAV concentration in respiratory fluid (# mm23) obtained by
assuming that the respiratory fluid contains the same concentra-
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tion of IAV as in nasal washes of infected persons (6.360.36106
median tissue culture infectious dose (TCID50) mL
21 [49]) and
that 1 TCID50 equals 1000 virus particles [50]; the term in the first
set of parentheses is the mean droplet volume for the bin; Di,upper
and Di,lower are, respectively, the upper and lower diameters of the
ith size bin (mm); ni is the droplet count for the ith size bin given in
Eq. 4, and V is the room volume (assumed to be 50 m3). The
solution for C is given in Eq. 3.
Removal efficiency of settling, ventilation, and
inactivation
Removal efficiency in this study refers to the percentage of IAVs
removed by a certain mechanism (i.e., settling, ventilation,
inactivation, or a combination of these three) at a given time
and RH. In Figure 5, removal efficiencies of settling (Esettling),
ventilation (Event), and inactivation (Einactivation), and total removal
efficiency (Etotal) are calculated by Eq. 10–13:
Esettling~1{ exp ({
v
H
t) ð10Þ
Event~1{ exp ({lt) ð11Þ
Einactivation~1{ exp ({kt) ð12Þ
Etotal~1{ exp½{( v
H
tzlzk)t ð13Þ
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